Racial Disparities Seen in US Food and Drug Administration Drug Approval Trials in Multiple Myeloma
According to the results of a study published in Blood Advances, Black and Hispanic patients appear to be underrepresented in global clinical trials supporting US Food and Drug Administration (FDA) […]